altus labs, llc

We will disrupt the $17B steroid and NSAID markets for conditions including atopic dermatitis, arthritis, and itch. Altus Labs creates active pharmaceutical ingredients (APIs), datasets, patented formulas, and products to provide new and safer options to patients and consumers. We are focused on the endocannabinoid system (ECS) in inflammatory and immune mediated diseases. We believe that the ECS plays a key role in the body's ability to maintain homeostasis, or balance. Imbalance leads to inflammation, which manifests in disease. Research is demonstrating that cannabinoids are directly and indirectly interacting with the ECS, and in doing so are promising molecules and compounds to treat, mitigate, and potentially prevent multiple disease states.